SCHEMBL4156445

SCHEMBL4156445

N[C@@H](CCCSCC(=O)C(F)(F)F)C(=O)NCCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CES1 P23141 4/20 0.59
HDAC1 Q13547 2/20 0.43
HDAC2 Q92769 1/20 0.43
MLYCD O95822 1/20 0.42
TLR2 O60603 1/20 0.41
MMP2 P08253 1/20 0.41
FAAH O00519 3/20 0.40
POLB P06746 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
PLAAT3 P53816 1/20 0.40
PLAAT5 Q96KN8 1/20 0.40
PLAAT2 Q9NWW9 1/20 0.40
PLAAT4 Q9UL19 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4169033 0.82 CES1 (0.52) CES1HDAC1HDAC2MMP2FAAH
Trifluoroacetic Acid SCHEMBL4304781 0.81 CES1 (0.50) CES1HDAC1HDAC2MMP2FAAH
SCHEMBL4156447 0.80 CES1 (0.59) CES1HDAC1HDAC2MLYCDFAAH
SCHEMBL4163608 0.77 CES1 (0.54) CES1HDAC1HDAC2FAAHCYP2D6
SCHEMBL4605724 0.76 CES1 (0.46) CES1HDAC1HDAC2
SCHEMBL4174326 0.76 KMT2A (0.52) CES1HDAC1HDAC2HDAC3HDAC4
SCHEMBL14444028 0.76 POLB (0.55) MMP2POLBPLAAT5PLAAT4CYP2D6
SCHEMBL8615413 0.76 DPP7 (0.60) TLR2POLBCYP2D6CYP2C9CYP2C19
SCHEMBL30889119 0.76 MMP2 (0.67) TLR2MMP2POLBCYP2D6CYP2C9
SCHEMBL4151724 0.75 MCHR1 (0.41) CES1HDAC1HDAC2HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors JONES PHILIP 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC5, HDAC1, HDAC11 CES1 1925/4885HDAC1 2/4885HDAC2 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.